Close Menu

JP Morgan Healthcare Conference

Gen-Probe just launched the Panther system in Europe with its initial menu focused on STD tests. The firm believes menu expansion will drive double-digit sales growth for years to come.

Officials from Qiagen, Cepheid, Gen-Probe, Celera, and Luminex provided updates on recently launched and upcoming assays and instrument systems.

Officials from the company said Thermo Fisher's R&D investments would target mass spectrometry, specialty diagnostics, and bioscience reagents.

Genomic Health will also hire additional sales people in connection with the launch, President and CEO Kim Popovits said yesterday at the JP Morgan Healthcare Conference.

A Beckman Coulter official provided an update on revenue guidance and the firm's pending molecular diagnostics system; while an Agilent executive discussed the company's pending Varian acquisition and new UHPLC system.

Pages

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.